{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T08:12:11Z","timestamp":1789719131153,"version":"4.0.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1016\/j.jconrel.2009.04.014","type":"journal-article","created":{"date-parts":[[2009,4,18]],"date-time":"2009-04-18T04:49:52Z","timestamp":1240030192000},"page":"16-23","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["In vitro and in vivo characterization on amorphous solid dispersion of cyclosporine A for inhalation therapy"],"prefix":"10.1016","volume":"138","author":[{"given":"Satomi","family":"Onoue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyuki","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Kawabata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Mizumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naofumi","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shizuo","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2009.04.014_bib1","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/BF01973261","article-title":"Biological effects of cyclosporin A: a new antilymphocytic agent","volume":"6","author":"Borel","year":"1976","journal-title":"Agents Actions"},{"key":"10.1016\/j.jconrel.2009.04.014_bib2","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/0091-6749(92)90331-U","article-title":"Is there a role for cyclosporine in asthma?","volume":"89","author":"Calderon","year":"1992","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jconrel.2009.04.014_bib3","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0014-2999(01)00975-X","article-title":"Effects of cyclosporin A administered into the airways against antigen-induced airway inflammation and hyperreactivity in the rat","volume":"420","author":"Underwood","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jconrel.2009.04.014_bib4","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1183\/09031936.95.08071091","article-title":"Treatment of steroid-dependent bronchial asthma with cyclosporin","volume":"8","author":"Nizankowska","year":"1995","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jconrel.2009.04.014_bib5","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1056\/NEJM198912213212507","article-title":"Cyclosporine","volume":"321","author":"Kahan","year":"1989","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2009.04.014_bib6","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1517\/13543776.18.4.429","article-title":"Dry powder inhalation systems for pulmonary delivery of therapeutic peptides and proteins","volume":"18","author":"Onoue","year":"2008","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.jconrel.2009.04.014_bib7","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1089\/jam.2007.0626","article-title":"Preclinical safety evaluation of inhaled cyclosporine in propylene glycol","volume":"20","author":"Wang","year":"2007","journal-title":"J. Aerosol Med."},{"key":"10.1016\/j.jconrel.2009.04.014_bib8","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1177\/009127000004001106","article-title":"Pharmacokinetics, pharmacodynamics, and safety of inhaled cyclosporin A (ADI628) after single and repeated administration in healthy male and female subjects and asthmatic patients","volume":"40","author":"Rohatagi","year":"2000","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.jconrel.2009.04.014_bib9","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1023\/B:PHAM.0000016235.32639.23","article-title":"Solubilizing excipients in oral and injectable formulations","volume":"21","author":"Strickley","year":"2004","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2009.04.014_bib10","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1023\/B:PHAM.0000033016.36825.2c","article-title":"Mishandling of the therapeutic peptide glucagon generates cytotoxic amyloidogenic fibrils","volume":"21","author":"Onoue","year":"2004","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2009.04.014_bib11","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ijpharm.2007.08.027","article-title":"Novel technology to prepare oral formulations for preclinical safety studies","volume":"350","author":"Niwa","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2009.04.014_bib12","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1002\/jps.2600600902","article-title":"Pharmaceutical applications of solid dispersion systems","volume":"60","author":"Chiou","year":"1971","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2009.04.014_bib13","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1002\/jps.10444","article-title":"Properties and stability of a liquid crystal form of cyclosporine\u2014the first reported naturally occurring peptide that exists as a thermotropic liquid crystal","volume":"92","author":"Lechuga-Ballesteros","year":"2003","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2009.04.014_bib14","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1080\/03639040600637606","article-title":"Characteristics of bicalutamide solid dispersions and improvement of the dissolution","volume":"32","author":"Ren","year":"2006","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jconrel.2009.04.014_bib15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0939-6411(00)00091-6","article-title":"Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards","volume":"50","author":"Lobenberg","year":"2000","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2009.04.014_bib16","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ijpharm.2004.11.018","article-title":"Erythritol-based dry powder of glucagon for pulmonary administration","volume":"290","author":"Endo","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2009.04.014_bib17","doi-asserted-by":"crossref","first-page":"L1","DOI":"10.1152\/ajplung.90200.2008","article-title":"Animal models of chronic obstructive pulmonary disease","volume":"295","author":"Wright","year":"2008","journal-title":"Am. J. Physiol., Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.jconrel.2009.04.014_bib18","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1165\/ajrcmb.12.3.7873190","article-title":"Allergen-induced airway inflammation and bronchial responsiveness in wild-type and interleukin-4-deficient mice","volume":"12","author":"Brusselle","year":"1995","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.jconrel.2009.04.014_bib19","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1183\/09031936.03.00018202","article-title":"A cyclosporin A\/maltosyl-alpha-cyclodextrin complex for inhalation therapy of asthma","volume":"22","author":"Fukaya","year":"2003","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jconrel.2009.04.014_bib20","first-page":"437","article-title":"The effect of omega-3 fatty acids and vitamin E on the nephrotoxicity of cyclosporin A in hereditary hypertriglyceridemic rats","volume":"48","author":"Bohdanecka","year":"1999","journal-title":"Physiol. Res."},{"key":"10.1016\/j.jconrel.2009.04.014_bib21","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/0140-6736(92)91646-P","article-title":"Trial of cyclosporin in corticosteroid-dependent chronic severe asthma","volume":"339","author":"Alexander","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2009.04.014_bib22","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1164\/ajrccm\/144.5.page","article-title":"Glucocorticoid resistance in chronic asthma. Peripheral blood T lymphocyte activation and comparison of the T lymphocyte inhibitory effects of glucocorticoids and cyclosporin A","volume":"144","author":"Corrigan","year":"1991","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.jconrel.2009.04.014_bib23","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jconrel.2007.02.004","article-title":"PLGA nanoparticles for oral delivery of cyclosporine: nephrotoxicity and pharmacokinetic studies in comparison to Sandimmune Neoral","volume":"119","author":"Italia","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2009.04.014_bib24","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1183\/09031936.04.00058504","article-title":"Aerosol cyclosporin therapy in lung transplant recipients with bronchiolitis obliterans","volume":"23","author":"Iacono","year":"2004","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jconrel.2009.04.014_bib25","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1517\/13543784.15.8.981","article-title":"Ciclosporin aerosol in lung transplantation","volume":"15","author":"Burckart","year":"2006","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.jconrel.2009.04.014_bib26","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1023\/A:1015905615404","article-title":"Liposomal formulation eliminates acute toxicity and pump incompatibility of parenteral cyclosporine","volume":"6","author":"Gruber","year":"1989","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2009.04.014_bib27","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1002\/jps.20898","article-title":"Gelatin-stabilised microemulsion-based organogels facilitates percutaneous penetration of Cyclosporin A in vitro and dermal pharmacokinetics in vivo","volume":"96","author":"Liu","year":"2007","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2009.04.014_bib28","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0039-6060(05)80349-6","article-title":"Efficacy of inhaled cyclosporine in lung transplant recipients with refractory rejection: correlation of intragraft cytokine gene expression with pulmonary function and histologic characteristics","volume":"118","author":"Keenan","year":"1995","journal-title":"Surgery"},{"key":"10.1016\/j.jconrel.2009.04.014_bib29","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3109\/10611869909085494","article-title":"Nebulizer-compatible liquid formulations for aerosol pulmonary delivery of hydrophobic drugs: glucocorticoids and cyclosporine","volume":"7","author":"Klyashchitsky","year":"1999","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2009.04.014_bib30","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1152\/japplphysiol.00970.2003","article-title":"Mucociliary and long-term particle clearance in the airways of healthy nonsmoker subjects","volume":"97","author":"Moller","year":"2004","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.jconrel.2009.04.014_bib31","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1164\/ajrccm\/142.2.434","article-title":"Mucosal inflammation in asthma","volume":"142","author":"Djukanovic","year":"1990","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.jconrel.2009.04.014_bib32","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1398-9995.1991.tb00590.x","article-title":"Cyclosporin for steroid-dependent asthma","volume":"46","author":"Szczeklik","year":"1991","journal-title":"Allergy"},{"key":"10.1016\/j.jconrel.2009.04.014_bib33","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3109\/01480549409014311","article-title":"Effects of cyclosporin on kidney glutathione metabolism and cytochrome P-450 in the rabbit: possible implication of eicosanoid metabolism","volume":"17","author":"Massicot","year":"1994","journal-title":"Drug Chem. Toxicol."},{"key":"10.1016\/j.jconrel.2009.04.014_bib34","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/S0024-3205(00)01028-6","article-title":"Preventive effect of platelet-activating factor antagonist, Y-24180, against cyclosporine-induced acute nephrotoxicity","volume":"68","author":"Kawaguchi","year":"2001","journal-title":"Life Sci."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365909002296?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365909002296?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:22:50Z","timestamp":1759159370000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365909002296"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["S0168365909002296"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2009.04.014","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro and in vivo characterization on amorphous solid dispersion of cyclosporine A for inhalation therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2009.04.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}